# CJC-1295 Reconstitution and Dosing: DAC Versus No-DAC in the Literature
> Note: PeptIQ is not a medical provider. This article is educational only. Published figures and community logs are not a protocol.
CJC-1295 is a tetrasubstituted analog of growth hormone-releasing hormone (GHRH). The version with a Drug Affinity Complex (DAC) can bind albumin and stay in circulation for days. The version without DAC, often sold as Mod GRF 1-29, is discussed as a short pulse measured in minutes. Teichman and colleagues reported prolonged GH and IGF-1 stimulation after a single administration of CJC-1295 (PubMed 16352683). ClinicalTrials.gov indexes related GH studies (search).
A reconstitution conversation that does not name DAC versus no-DAC is incomplete. The same milligram label can imply weekly or multiple-daily exposure depending on the analog.
Evidence tier
| Layer | What it shows | What it does not |
|---|
| Teichman 2006 and related GH papers | Multi-day GH/IGF-1 elevation after DAC-form exposure in study volunteers | A consumer vial schedule |
| GHRH plus GHRP synergy papers | Pharmacologic rationale for pairing a GHRH analog with a secretagogue | Proof that a specific stack is indicated |
| Community tables | Microgram bands and pin frequency by DAC status | Safety or efficacy |
Bowers and colleagues described synergistic GH release when GHRH and a GH-releasing peptide were combined in men (PubMed 2108187). Synergy in a study is not a mixing instruction.
Lyophilized-vial math
Educational write-ups use the same concentration formula as other freeze-dried peptides:
Concentration (mcg/mL) = (vial mg × 1,000) ÷ diluent mL
Volume (mL) = desired mcg ÷ concentration
Illustrative examples only
A vial labeled 2 mg with 2 mL bacteriostatic water is 1,000 mcg/mL. A 100 mcg discussion figure would be 0.10 mL (10 units on a U-100 syringe). A 5 mg vial with 2 mL is 2,500 mcg/mL, so 100 mcg is 0.04 mL (4 units), which is a small draw and easy to misread.
Those examples exist to show why vial size and water volume dominate the syringe reading. They are not a recommended reconstitution.
Bacteriostatic water is the diluent named most often for multi-draw research vials. Cold, dark storage for the dry cake and refrigeration after reconstitution are the usual handling claims. Beyond-use dating on unlabeled vials is not standardized.
Research-reference ranges
Teichman's CJC-1295 study used microgram-per-kilogram single doses in a clinical research setting, then followed GH and IGF-1 for days. That is a pharmacokinetic experiment. It is not a weekly 2 mg community habit dressed up as a trial arm.
Community education usually splits:
| Analog people think they have | Cadence they discuss | How to read it |
|---|
| With DAC | Less frequent, often weekly narratives | Matches long half-life story, not a label |
| No DAC / Mod GRF 1-29 | Same sitting as a GHRP, more frequent | Matches short pulse story, not a label |
PeptIQ users who log CJC-1295 often pair it with ipamorelin in the same session. That is a logging correlation. It is not a finding that the pair is indicated.
Typical community microgram bands for the no-DAC analog sit in the low hundreds of micrograms per administration. DAC-form community tables more often use milligrams less often. Both are uncontrolled conventions. Published mg/kg study doses do not automatically equal those tables.
Route language
Study papers and community education both talk about subcutaneous administration for these analogs. That is a route description. It is not an injection walkthrough. Secretagogues are often described as more fragile in mixed syringes than simpler repair peptides. Separate draws remove a chemistry unknown. That is a risk comment, not a technique lesson.
For analog differences without the math, see the DAC versus no-DAC comparison guide and the CJC-1295 plus ipamorelin stack explainer.
Bottom line
Name the analog first. DAC and no-DAC are different exposure patterns in the literature. Reconstitution arithmetic is generic. Dose calendars on forums are not Teichman 2006. Educational use only.